Carmine Therapeutics Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 1-10 Employees

Carmine Therapeutics revenue & valuation

Annual revenue	$3,500,000
Revenue per employee	$584,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,200,000
Total funding	No funding

Key Contact at Carmine Therapeutics

Tenzin Gocha

President

Company overview

Headquarters	700 Main St, LabCentral, Cambridge, Massachusetts 02139, US
Website	carminetherapeutics.com
NAICS	541714
Keywords	Biotech, Rare Diseases, Therapeutics, Platform Technologies, Red Blood Cell Extracellular Vesicles, Non-Viral Gene Therapy
Founded	2019
Employees	1-10
Socials

Carmine Therapeutics Email Formats

Carmine Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@carminetherapeutics.com), used 50% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@carminetherapeutics.com	50%
{first name}.{last name}	john.doe@carminetherapeutics.com	50%

About Carmine Therapeutics

Carmine Therapeutics, headquartered in Cambridge MA, is pioneering a new class of non-viral gene therapies based on red blood cell extracellular vesicles, combined with proprietary payloads. In June 2020, Carmine inked a research alliance with Takeda Pharmaceuticals worth up to $900 million to develop non-viral gene therapies for 2 targets. Carmine has also been named one of the FierceBiotech’s Fierce 15 Biotech companies of 2020 and was also awarded the Bristol-Myers Squibb "Golden Ticket". Carmine was founded in 2019 by EVX Ventures, Professors Harvey Lodish (Whitehead, MIT), Minh Le and Jiahai Shi. Professor Lodish, who was a founding member of several successful biotech companies that include Genzyme and Millennium Pharmaceuticals, is also Chair of the Scientific Advisory Board of Carmine. For more information, visit www.carminetherapeutics.com Media Relations Media@carminetherapeutics.com Investor Relations Investors@carminetherapeutics.com

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Founder/Owner

Vice President

Funding Data

Explore Carmine Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-11-13	4	N/A

Funding Insights

Number of funding rounds

Carmine Therapeutics Tech Stack

Discover the technologies and tools that power Carmine Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Lodash

JavaScript libraries

Sentry

Issue trackers

Sirvoy

Appointment scheduling

Google Tag Manager

Tag managers

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Google Cloud

IaaS

Google Analytics

Analytics

Google Cloud CDN

CDN

Frequently asked questions

Carmine Therapeutics is located in Cambridge, Massachusetts, US.

Carmine Therapeutics generates an estimated annual revenue of $3,500,000. This revenue figure reflects the company's market position and business performance in its industry.

Carmine Therapeutics has an estimated valuation of $11,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Carmine Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Carmine Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Carmine Therapeutics

Tenzin Gocha

President

4.8

40,000 users